Group One Trading, L.P. Cassava Sciences Inc Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 130,789 shares of SAVA stock, worth $307,354. This represents 0.16% of its overall portfolio holdings.

Number of Shares
130,789
Holding current value
$307,354
% of portfolio
0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$9.57 - $35.08 $1.25 Million - $4.59 Million
130,789 New
130,789 $3.85 Million
Q1 2024

May 10, 2024
BUY
$18.44 - $26.41 $86,557 - $123,968
4,694 New
4,694 $95,000
Q2 2023

Aug 09, 2023
BUY
$21.59 - $27.88 $991,758 - $1.28 Million
45,936 New
45,936 $1.13 Million
Q4 2022

Feb 09, 2023
BUY
$27.82 - $44.16 $2.91 Million - $4.62 Million
104,520 New
104,520 $3.09 Million
Q2 2022

Aug 11, 2022
SELL
$17.22 - $38.47 $3.53 Million - $7.89 Million
-205,082 Reduced 89.65%
23,682 $666,000
Q1 2022

May 12, 2022
BUY
$32.6 - $53.05 $4.63 Million - $7.54 Million
142,102 Added 163.97%
228,764 $8.5 Million
Q4 2021

Feb 11, 2022
SELL
$36.77 - $90.91 $11.8 Million - $29.2 Million
-321,190 Reduced 78.75%
86,662 $3.79 Million
Q3 2021

Nov 12, 2021
SELL
$41.79 - $135.3 $5.71 Million - $18.5 Million
-136,733 Reduced 25.11%
407,852 $25.3 Million
Q2 2021

Aug 10, 2021
BUY
$32.15 - $89.72 $3.99 Million - $11.1 Million
124,202 Added 29.54%
544,585 $46.5 Million
Q1 2021

May 12, 2021
BUY
$7.09 - $87.95 $2.54 Million - $31.5 Million
358,594 Added 580.35%
420,383 $18.9 Million
Q4 2020

Feb 10, 2021
SELL
$6.79 - $12.25 $416,770 - $751,905
-61,380 Reduced 49.83%
61,789 $421,000
Q3 2020

Nov 12, 2020
SELL
$2.86 - $11.51 $281,601 - $1.13 Million
-98,462 Reduced 44.43%
123,169 $1.42 Million
Q2 2020

Aug 13, 2020
BUY
$2.04 - $9.64 $432,561 - $2.04 Million
212,040 Added 2210.82%
221,631 $683,000
Q1 2020

May 13, 2020
BUY
$3.26 - $9.65 $30,800 - $91,173
9,448 Added 6606.99%
9,591 $39,000
Q1 2019

May 13, 2019
BUY
$0.92 - $1.29 $131 - $184
143 New
143 $0

Others Institutions Holding SAVA

# of Institutions
207
Shares Held
14M
Call Options Held
2.98M
Put Options Held
6.57M
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $94.2M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email